Global ETF Survey 2026: Answer now →
Help us improve your experience. Please confirm your investor type:
From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

The top performer ARK Genomic Revolution ETF or ARKG, invests in industries of the health care sector, including companies involved in the biotechnology industry.
By Rony Abboud
October 19, 2021
Advertisement
Cathie Wood's popular thematic ETFs ARK Genomic Revolution ETF (+3.44%), ARK Innovation ETF (+2.18%), ARK Autonomous Technology & Robotics ETF (+1.92%), ARK Next Generation Internet ETF (+1.74%), ARK Space Exploration & Innovation ETF (+1.45%) and ARK Fintech Innovation ETF (+1.26%) flashed green on Tuesday, as investors’ risk appetite for technology shares replenish on strong earnings reports.
The top performer ARK Genomic Revolution ETF or ARKG, invests in industries of the health care sector, including companies involved in the biotechnology industry, mainly leaders in CRISPR, targeted therapeutics, bioinformatics, molecular diagnostics, stem cells and agricultural biology. The fund, with high exposure to North America (93%) holds 53 companies including Teladoc Health (7.98%), Exact Sciences Corp. (5.19%), Pacific Biosciences (4.91%), Fate Therapeutics (4%) and Vertex Pharmaceuticals (3.7%). Since inception on October 31st, 2014, the fund grew to $6.96 billion in assets and generated more than +300% in returns.
From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.
ARKG trades primarily on the Cboe BZX and charges an annual fee of 0.75%.
Find and compare over 10,000 ETFs with our free tools: 
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about Trackinsight